started · updated
InfectoPharm launches OtoAir nasal balloon devices for ear ventilation
InfectoPharm Arzneimittel and Consilium GmbH announced the market launch of two new medical devices, the OtoAir® nasal balloon and the OtoAir® soft nasal balloon, on 30 July 2026. The products are listed as reimbursable aids under the German statutory health insurance (GKV) and are intended for non‑invasive treatment of middle‑ear ventilation disorders such as otitis media with effusion (Paukenerguss).
The standard OtoAir® balloon is suitable for patients aged three years and older, while the soft version is designed for children from two years, offering a lower inflation pressure. Each kit contains one nasal piece and six balloons and carries a QR code linking to a child‑friendly instructional video. Clinical guidelines, including the DGPI handbook, endorse nasal‑balloon ventilation as a conservative therapy for middle‑ear effusion.
The devices are marketed for use in adults and children, including scenarios such as pressure changes during flying or diving, and are positioned as a gentle alternative to more invasive interventions.
Entities
Consilium GmbH · DGPI · German statutory health insurance (GKV) · InfectoPharm Arzneimittel · OtoAir Nasal Balloon
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 3 SOURCES] Inflating the balloon creates negative pressure that opens the eustachian tube and equalises middle‑ear pressure. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] Each package contains one nasal piece and six medical balloons. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] The devices are reimbursable medical products covered by the German statutory health insurance (GKV). www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] InfectoPharm Arzneimittel and Consilium GmbH launched OtoAir® nasal balloon and OtoAir® soft nasal balloon on 30 July 2026. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] The DGPI handbook and clinical guidelines recommend middle‑ear ventilation via nasal balloon as a conservative therapy for otitis media with effusion. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] The devices treat ventilation disorders of the middle ear, such as otitis media with effusion (Paukenerguss). www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] Product packaging includes a QR code linking to a child‑friendly application video. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de
- [● 3 SOURCES] OtoAir® nasal balloon is intended for patients aged three years and older; OtoAir® soft is suitable for children from two years. www.pr-echo.de · www.go-with-us.de · www.pr-neuigkeiten.de